DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dilantin-125 (Phenytoin) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dilantin-125 (Phenytoin) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Dilantin-125 side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient: female

Reactions: Tubulointerstitial Nephritis, Hypersensitivity, Hepatitis, Stevens-Johnson Syndrome

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Dilantin-125



Possible Dilantin-125 side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-19

Patient: female

Reactions: Abdominal Pain, Pneumonia, Anaemia, Malnutrition, Constipation, Convulsion, Impaired Gastric Emptying, Drug Level Decreased, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Phenytoin
    Dosage: 100 mg, 2 caps daily am, + 2 pm
    Administration route: Oral
    Indication: Convulsion

Butrans
    Dosage: 10 mcg/hr, weekly
    Indication: Osteoarthritis
    Start date: 2012-01-17
    End date: 2012-03-12

Dilantin-125
    Dosage: 160mg every am and 200mg every pm
    Indication: Convulsion
    Start date: 2007-08-09

Morphine Sulfate
    Dosage: 15 mg, immediate release every 4 hours as needed
    Indication: Breakthrough Pain

Butrans
    Indication: Breakthrough Pain

Tramadol HCL
    Indication: Breakthrough Pain

Tramadol HCL
    Dosage: 50 mg, 4x/day every 6 hours
    Indication: Osteoarthritis
    Start date: 2012-02-14

Other drugs received by patient: Prednisone; Guaifenesin; Senokot; Colace; Protonix; Duoneb; Prednisone; Bisacodyl; Azithromycin; Dilantin; Clonidine; Zofran; Ceftin; Citalopram; Loratadine



Possible Dilantin-125 side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02

Patient: female

Reactions: Pneumonia, Anticonvulsant Drug Level Decreased, Drug Level Decreased, Convulsion

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Butrans
    Dosage: 10 mcg/hr, weekly
    Indication: Osteoarthritis
    Start date: 2012-01-17
    End date: 2012-03-12

Tramadol HCL
    Dosage: 50 mg, 4x/day every 6 hours
    Indication: Osteoarthritis
    Start date: 2012-02-14

Butrans
    Indication: Breakthrough Pain

Dilantin-125
    Dosage: 160mg every am and 200mg every pm
    Indication: Convulsion
    Start date: 2007-08-09

Morphine Sulfate
    Dosage: unk
    Indication: Breakthrough Pain

Tramadol HCL
    Indication: Breakthrough Pain



Possible Dilantin-125 side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-24

Patient: female

Reactions: Pneumonia, Drug Level Decreased, Convulsion

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Dilantin-125
    Dosage: 160mg every am and 200mg every pm
    Indication: Convulsion
    Start date: 2007-08-09

Morphine Sulfate
    Dosage: unk
    Indication: Breakthrough Pain

Butrans
    Dosage: 10 mcg/hr, weekly
    Indication: Osteoarthritis
    Start date: 2012-01-17
    End date: 2012-03-12

Tramadol HCL
    Indication: Breakthrough Pain

Butrans
    Indication: Breakthrough Pain

Tramadol HCL
    Dosage: 50 mg, 4x/day every 6 hours
    Indication: Osteoarthritis
    Start date: 2012-02-14

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017